Answers are grounded in this paper and cite their sources.
Research demonstrates transformative therapies improving outcomes in sickle cell disease, suggesting significant advancements in treatment options.
Key points Sickle cell disease (SCD) occurs when a DNA base pair substitution in the β-globin gene results in the formation of hemoglobin S, which polymerizes when deoxygenated, leading to deformation (“sickling”) and hemolysis of red blood cells. Sickle cell disease results in recurrent acute
No takes yet. Share an insight, caveat, or question.
Jamani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: